Context Therapeutics CNTX
NASDAQ CNTX
$0.24 +0.01 (+4.35%)
At close: Oct 22, 2026 · 4:00 PM EDT

Context Therapeutics (CNTX) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Context Therapeutics (CNTX) posted Return on Capital Employed [ROCE] of -109.22% for Q2 2026, down 64.43 percentage points from -44.79% a year earlier and down 33.07 percentage points from the prior quarter.

Analysis

Context Therapeutics (CNTX) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Context Therapeutics' Return on Capital Employed [ROCE] came in at -52.73%, up 2.33 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a four-year change of -6.67 percentage points (FY2021 to FY2025).
  • In prior years, Context Therapeutics' Return on Capital Employed [ROCE] was -55.06% in FY2024 (+54.80 pp), -109.86% in FY2023 (-72.73 pp), -37.13% in FY2022 (+8.93 pp) and -46.06% in FY2021.
  • The Q2 2026 figure stands as the lowest quarterly Return on Capital Employed [ROCE] since Q1 2024.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has declined in each of the last five quarters, with an average year-over-year change of +27.99 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q1 2025, with a gain of 169.26 percentage points; the weakest was Q1 2024, with a drop of 144.40 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -76.16% (Q1 2026), -60.30% (Q4 2025) and -39.15% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 17.52%
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 17.92%
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 6.28%
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 19.32%
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 16.76%
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 16.66%
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -5.97%
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 11.86%
10 Context Therapeutics 22.05 Mn -218.41 Mn - -109.22%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -109.22%
Mar 31, 2026 -76.16%
Dec 31, 2025 -60.30%
Sep 30, 2025 -39.15%
Jun 30, 2025 -44.79%
Mar 31, 2025 -33.78%
Dec 31, 2024 -33.44%
Sep 30, 2024 -35.30%
Jun 30, 2024 -36.23%
Mar 31, 2024 -203.03%
Dec 31, 2023 -163.51%
Sep 30, 2023 -106.02%
Jun 30, 2023 -76.18%
Mar 31, 2023 -58.63%
Dec 31, 2022 -41.78%
Sep 30, 2022 -37.05%
Jun 30, 2022 -28.28%
Mar 31, 2022 -27.60%
Dec 31, 2021 -44.32%
API Access

Context Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CNTX&period=max&api_key=YOUR_API_KEY